BRCA1 and neoplasm: This study is enrolling patients with stage III breast cancer treated with adjuvant or neoadjuvant chemotherapy and with features of HRD, as defined as either known gBRCA1/2m or BRCA1-like copy number profile evaluated on tumor tissue.